These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7331494)

  • 1. [Use of the human lymphocyte transformation test to detect a biologically active cholera toxin in Vibrio cholerae culture filtrates].
    Nikolaeva IS; Gaĭlonskaia IN; Ferapontov GK; Astashkin EI
    Vestn Akad Med Nauk SSSR; 1981; (12):62-7. PubMed ID: 7331494
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.
    Blanco LP; DiRita VJ
    Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic recognition of pertussis and cholera toxin by the same antipeptide antibodies.
    Presentini R; Perin F; Ancilli G; Rappuoli R; Bartoloni A; Lozzi L; Neri P; Antoni G
    Ann Sclavo Collana Monogr; 1986; 3(1-2):283-8. PubMed ID: 2892508
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the ELISA method for cholera toxin determination in Vibrio cholerae cultures].
    González-Bonilla C; Gutiérrez-Cogco L; Moguel-Pech L; Villanueva-Zamudio A
    Rev Latinoam Microbiol; 1994; 36(4):273-6. PubMed ID: 7701137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotonic and cytotoxic effect of cholera toxin on Vero cells and its relation to PCR].
    Rodríguez-Angeles MG; Giono-Cerezo S; Valdespino-Gómez JL
    Rev Latinoam Microbiol; 1994; 36(4):263-71. PubMed ID: 7701136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to Vibrio cholerae somatic and enterotoxin antigens in human colostrum.
    Majumdar AS; Ghosh AK; Pal SC; Ghose AC
    Indian J Med Res; 1982 Apr; 75():474-9. PubMed ID: 7106887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Toxigenic Vibrio cholerae non-01].
    Bravo L; Ramírez M; Maestre JL; Llop A; Cabrera R; García B; Fernández A; Castañeda N
    Rev Cubana Med Trop; 2000; 52(2):106-9. PubMed ID: 11107903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibrio cholerae: cholera toxin.
    Vanden Broeck D; Horvath C; De Wolf MJ
    Int J Biochem Cell Biol; 2007; 39(10):1771-5. PubMed ID: 17716938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants.
    Mekalanos JJ; Collier RJ; Romig WR
    Infect Immun; 1978 May; 20(2):552-8. PubMed ID: 669812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunobiological relationships between Vibrio fluvialis and Vibrio cholerae enterotoxins.
    Ahsan CR; Sanyal SC; Zaman A; Neogy PK; Huq MI
    Immunol Cell Biol; 1988 Jan; 66 ( Pt 3)():251-2. PubMed ID: 3155161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytotoxic effect of Vibrio cholerae non-O1 on Vero cells].
    Figueroa-Arredondo P; García-Lozano H; Gutiérrez-Cogco L; Valdespino-Gómez JL
    Rev Latinoam Microbiol; 1994; 36(4):277-81. PubMed ID: 7701138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic control of Vibrio cholerae pathogenicity: the temperate filamentous phage CTX, coding for cholera toxin and the "island of pathogenicity"].
    Smirnova NI
    Mol Gen Mikrobiol Virusol; 1999; (4):3-11. PubMed ID: 10621931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of mucosal immunity.
    Lewis DJ; Hayward CM
    Methods Mol Med; 2003; 87():245-54. PubMed ID: 12958460
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxin-coregulated pilus-loaded microparticles as a vaccine against Vibrio cholerae O139.
    Du Y; Jia WX; Liu L
    Chin Med J (Engl); 2004 Apr; 117(4):618-20. PubMed ID: 15109462
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved purification process for cholera toxin and its application to the quantification of residual toxin in cholera vaccines.
    Jang H; Kim HS; Kim JA; Seo JH; Carbis R
    J Microbiol Biotechnol; 2009 Jan; 19(1):108-12. PubMed ID: 19190416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Method of extracting cholera toxin from solid media containing cultured vibrios].
    Efremenko VI; Vladimtseva IV; Durikhin KV; Popova AE; Dolmatova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):68-71. PubMed ID: 7445852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protein preparation from Mycobacterium kansasii culture filtrate has biological activity similar to that of hCG and cholera toxin in human cell lines.
    Affronti LF; Dashner R
    Microbios; 1987; 52(211):87-96. PubMed ID: 2447470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis].
    Smirnova NI; Krepostnova IM; Livanova LF; Zadnova SP; Eremin SA; Il'ina TS
    Mol Gen Mikrobiol Virusol; 2007; (4):7-13. PubMed ID: 18154075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.